摘要
目的:探讨检测腹腔冲洗液中L3-PP和整合素α5β1对于预测胃癌腹膜种植转移的意义。方法:收集96例胃癌患者腹腔冲洗液,用RT-PCR方法测定冲洗液中游离细胞L3-PP、整合素α5β1及CEA mRNA的表达情况,同时作冲洗液细胞学检查(PLC)。结果:腹腔冲洗液中的L3-PP、α5β1和CEA mRNA的阳性率分别为74.0%(71/96)、65.6%(63/96)和62.5%(60/96),均高于腹腔冲洗液细胞学21.9%(21/96),差异均有统计学意义,χ2值分别为52.174、37.333和32.480,P值均<0.01。L3-PP、α5β1及CEA mRNA的阳性率与肿瘤的浸润深度(χ2=7.898,P=0.046;χ2=10.692,P=0.014;χ2=7.897,P=0.048)、TNM分期(χ2=21.960,P<0.01;χ2=29.266,P<0.01;χ2=22.291,P<0.01)、腹膜转移(χ2=13.919,P<0.01;χ2=16.627,P<0.01;χ2=9.089,P<0.01)等密切相关。对CEA-组和CEA+组的生存分析发现差异均有统计学意义(Log-rank test=8.349,P=0.039;Log-rank test=10.864,P=0.012)。结论:用RT-PCR联合检测腹腔冲洗液中L3-PP和整合素α5β1mRNA可作为预测胃癌腹膜种植转移的方法,为临床医生选择合适的治疗方案提供依据。
OBJECTIVE: To explore the expression of 1.3-PP and a5B1-integrin of peritoneal washing and their sig nificanees in the prediction of peritoneal metastasis of gastric cancer. METHODS: The peritoneal washings were collected during laparotomy from 96 patients with gastric cancer. The expression of 1.3-PP,a5fll-integrin and CEA mRNA were de- tected by reverse transcription polymerase chain reaction (RT PCR). RESULTS: The positive expression rates of 1.3 PP, a5B1 and CEA mRNA were 7,1. 0% (21/96),65. 6% (63/96) and 62. 5% (60/96),respectively,which were higher than that of cytological examination 21.8%(21/96),and there were statistically significant difference( X2=52. 174,P(0.01 X2= 37. 333,P〈0.01 ;X2=32. 480,P(0.01,respectively). The postive expression rates of [.3-PP,a5B1 and CEA mRNA were correlated with the depth of invasion( X2 = 7. 898, P= 0. 046 ; X2= 10. 692, P= 0.01,X2 = 7. 897. P = 0. 048, respec- tively). TNM staging( X2= 21. 960, P〈0.01 ; X2= 29. 266, P〈0.01 ; X2 = 22.291, P〈0.01, respectively), peritoneal dis- semination(xe 13.919,P〈0.01;X2=16.627,P〈0.01;X2=9.089,P〈0.01,respectively). The survival analysis of CEA negative group and CEA positive group were statistically significant difference( Log-rank test = 8.3,19, P = 0. 039; l.og-rank test= 10. 864 ,P= 0. 012, respectively). CONCLUSIONS: The detection of 1.3-PP and a5B1-integrin mRNA by RT-PCR may be used as a new method for predicting peritoneal implantation metastasis of gastric cancer,and provide an evidence for clinicians to select appropriate therapeutic scheme.
出处
《中华肿瘤防治杂志》
CAS
北大核心
2013年第4期281-284,共4页
Chinese Journal of Cancer Prevention and Treatment